ALT, NGM

Altimmune, Inc. (ALT)

Price (as of October 24)

10.83USD

Correlations

The correlation describes the statistical relationship between the value of two assets over time. Use this relationship to bet against an asset without shorting it or diversify your portfolio more effectively. Learn how you can use correlations to your advantage.

Lowest within Industry

Symbol Correlation

ICVX

Icosavax, Inc.

-0.13

IMMX

Immix Biopharma, Inc.

-0.13

MIRO

Miromatrix Medical Inc.

-0.1

JANX

Janux Therapeutics, Inc.

-0.1

SNPX

Synaptogenix, Inc.

-0.09

NBTX

Nanobiotix S.A.

-0.09

SLS

SELLAS Life Sciences Group, Inc.

-0.09

ROIV

Roivant Sciences Ltd.

-0.08

TNYA

Tenaya Therapeutics, Inc.

-0.08

SANA

Sana Biotechnology, Inc.

-0.08

Show more

Highest within Industry

Symbol Correlation

ALXO

ALX Oncology Holdings Inc.

0.23

ALVR

AlloVir, Inc.

0.22

ANGN

Angion Biomedica Corp.

0.21

AMTI

Applied Molecular Transport Inc.

0.2

ANNX

Annexon, Inc.

0.18

AVRO

AVROBIO, Inc.

0.17

OMGA

Omega Therapeutics, Inc.

0.17

ALLO

Allogene Therapeutics, Inc.

0.16

CINC

CinCor Pharma, Inc.

0.16

AMLX

Amylyx Pharmaceuticals, Inc.

0.16

Show more

Profile

Sector:
Healthcare
Industry:
Biotechnology

Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company’s lead product candidate, pemvidutide (proposed INN, formerly known as ALT-801), is a GLP-1/glucagon dual receptor agonist that is in Phase 1b trial for the treatment of obesity and non-alcoholic steatohepatitis. It is also developing HepTcell, an immunotherapeutic product candidate, which is in Phase 2 clinical trial for patients chronically infected with the hepatitis B virus. The company was formerly known as Vaxin Inc. and changed its name to Altimmune, Inc. in September 2015. Altimmune, Inc. was founded in 1997 is headquartered in Gaithersburg, Maryland.